Related Compounds
Compounds connected by the same goals, effects, or research topics.
Herb Profile
Curcumin
Curcuma longa
Curcumin (Curcuma longa) carries a Grade A rating — strong evidence.
Last reviewed: •7 sources citedReport a correctionProfile-wide ·A Strong
Use extra caution — GI upset; bleeding risk at high dose Details
- Evidence
- Strong Evidence
- Typical onset
- Varies by prep
- Safety rating
- Moderate caution
- Best for
- Anti Inflammatory, Analgesic, Inflammatory signaling, Metabolic health
- Avoid / review if
- Anticoagulants
Verdict: CurcuminMaybe
Bottom line
The joint-pain evidence is real and repeatedly replicated, but plain curcumin is barely absorbed — the formulation decides whether you get the studied effect or nothing at all. Buy a standardized, absorption-enhanced extract or skip it.
- Evidence confidence
- Moderate — a large trial base for joint pain, weakened by bioavailability and bias problems
- Expected onset
- 4–8 weeks for joint symptoms
- Give it
- 8–12 weeks
Safety: Generally well tolerated, though rare liver-injury reports cluster around high-bioavailability formulations. It can add to the effect of anticoagulants and is best avoided with gallstones or bile-duct obstruction.
On the evidence: Many randomized trials and meta-analyses support osteoarthritis pain relief; the literature also carries well-documented risks of bias, small samples, and assay-interference artefacts.
Best for
- Knee osteoarthritis pain and stiffness
- Inflammatory markers alongside standard care
- People willing to buy a genuinely absorbable formulation
Not ideal for
- Anyone relying on culinary turmeric powder to do the job
- Gallstones or bile-duct obstruction
- People on anticoagulants without clinician review
Consider instead: Boswellia — for joint pain when curcumin formulations upset your stomach
How strong is the evidence?Moderate
Why not higher
- Many trials are small, short, and at high risk of bias
- Formulations differ so widely that trials are hard to pool honestly
- Curcumin is a known assay-interference compound, so some mechanistic findings overstate it
Why not lower
- Multiple meta-analyses converge on real osteoarthritis pain relief
- Effects on inflammatory markers are reproducible across independent groups
- Short-term tolerability is well established
Practical takeaway: Worth an 8–12 week trial for knee osteoarthritis using a standardized, absorption-enhanced extract. Judge it on function and pain, and stop if nothing changes.
Safety
Safety & Cautions
GI upset; bleeding risk at high dose
Elevated caution
Caution level: Elevated. One caution category applies — read it before use.
- Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
Detailed safety fields
Pregnancy, breastfeeding, and contraindications
- Anticoagulants
Safety classifications
- Anticoagulant Caution: Bleeding or anticoagulant-adjacent caution language is present.
Full safety note
- GI upset; bleeding risk at high dose
Safety labels
- Anticoagulant Caution
Evidence-based safety
Caution when combined
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
High-Priority Caution
147 flagged pairingsBleeding / anticoagulant risk
High-Priority Caution
147 flagged pairingsBleeding / anticoagulant risk
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Bleeding / anticoagulant riskCertainty: Theoretical
Data provenance recorded for 147 of 147 pairings in this mechanism group.
- aescin — Theoretical interaction certainty
- Aged Garlic Extract — Theoretical interaction certainty
- ajoene — Theoretical interaction certainty
- Ajwain — Theoretical interaction certainty
- Allicin — Theoretical interaction certainty
- Garlic — Theoretical interaction certainty
- American Ginseng Extract — Theoretical interaction certainty
- Andrographis — Theoretical interaction certainty
- Angelica Archangelica — Theoretical interaction certainty
- Angelica Dahurica — Theoretical interaction certainty
- Angelica Pubescens — Theoretical interaction certainty
- Angelica Root — Theoretical interaction certainty
+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Evidence Summary
Evidence lens
Most useful for practical interpretation when safety context also fits.
StrongStrong Evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Metabolic Regulation · NF KB Modulation
Research maturity: Established research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — GI upset; bleeding risk at high dose
This profile cites 7 human studies.
Study design details
Evidence Grade
Grade A: Strong Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Meta-analysis
- Risk of Bias
- Low
- Consistency
- Consistent
Strongest recorded design is a meta-analysis, drawn from 22 recorded studies, 19 in people. No disagreement is recorded across them.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (17)9 human evidence sources · 2 human trials · ~2,456 participants across 2 human evidence sources with reported N · Consistency not yet classifiable
Filter by study class
Showing 17 of 17 studies.
What the evidence actually shows
This table contains 17 structured sources, including 9 human evidence sources; 2 are human trials. Across 2 human evidence sources with a reported sample size, the approximate participant total is 2,456; overlapping publications may include some of the same people.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Zeng L et al. · Front Immunol · 2022 Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | n=2396 | — | — | — | — | — | PubMed → |
PubMed · J Med Food · 2016 Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | — | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Depressive symptoms improved (SMD -0.65, 95% CI -1.16 to -0.13; I²=93%); anxiety symptoms improved modestly (SMD -0.22, 95% CI -0.40 to -0.05; I²=0%). | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Pooled analyses favored curcumin for depressive symptoms, but heterogeneity was high and sensitivity analyses showed fragility. | Eight depression trials: SMD -0.76 (95% CI -1.22 to -0.30; p=0.001; I²=94.5%). Eleven depressive-symptom trials: SMD -0.53 (95% CI -0.97 to -0.09; p=0.019; I²=85.7%). | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Adds a high-acuity clinical-population synthesis; apparent benefits should remain population-specific. | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | CRP and TNF decreased; ESR, IL-1β, IL-6, and PGE2 did not clearly differ. | PubMed → |
Show 11 more studies
A critical review of systematic reviews and meta-analyses of curcumin for knee osteoarthritis Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | Potential efficacy and safety signals were found, but methodological/reporting quality of the review literature was extremely low. | PubMed → |
Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial PubMed · Phytother Res · 2014 Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | n=60 | — | — | — | — | — | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Observed time-related improvements across both groups suggest nonspecific behavioral/lifestyle or placebo effects rather than a demonstrated supplement-specific benefit. | PubMed → |
Curcumin (Turmeric) and cancer Unlu A et al. · J BUON · 2016 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health Kocaadam B et al. · Crit Rev Food Sci Nutr · 2017 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
PubMed · Altern Med Rev · 2009 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | Broad possible benefits were reported, but with substantial uncertainty and generally weak methodological quality. | PubMed → |
Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | Pain and function generally favored curcumin, but heterogeneity was substantial and only a subset of reviews were high quality. | PubMed → |
Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | Reported reductions in CRP, TNF, IL-6, MDA, and PWV and increases in FMD and several antioxidant-enzyme markers; TAC was not clearly improved. | PubMed → |
The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | Across meta-analyses, curcumin showed favorable pain, function, and stiffness signals. | PubMed → |
Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | Higher-level evidence supports favorable changes in selected lipid measures. | PubMed → |
Dosing & Timing
- Dose guidance
- 500 1500 mg/day (bioavailable forms)
How Curcumin works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Curcumin Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
- Inflammatory Signaling Modulation
- Metabolic Regulation
- NF KB Modulation
Compare related active botanicals
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Guides that use Curcumin
Goal guides
Condition guides
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Turmeric / Curcumin product picks
Recommendation status
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
Product form & quality guidelines
When sourcing Curcumin, verify the label for:
- Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
- Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
- Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.
Continue comparing
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Curcumin research notes
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.